Chapman RH

No ORCID on file · 2 papers in corpus · active 2019
2019
PharmacoEconomics ·doi:10.1007/s40273-019-00832-2

Transparency in decision modeling remains a topic of rigorous debate among healthcare stakeholders, given tensions between the potential benefits of external access during model development and the need to protect intellectual property and …

2019
Journal of managed care & specialty pharmacy ·doi:10.18553/jmcp.2019.25.5.521

There is currently a movement to make economic models more transparent, with some arguing for completely open-source models. However, increasing model transparency raises several logistical challenges, including ownership and funding. This …